|Bid||59.70 x 1000|
|Ask||61.95 x 4000|
|Day's Range||60.15 - 62.50|
|52 Week Range||23.30 - 62.80|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 5, 2018 - Nov 9, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||69.00|
Next week, the trade war with China version 2.0 begins. The U.S. will slap tariffs on $200 billion worth of Chinese goods headed to the U.S. How will this affect which stocks to buy? Well, this has hardly rattled the broad markets — as a matter of fact, that they’re acting as they do when they get any good news. Realistic news that the trade war is having an effect is punished for merely being uttered.
BioTelemetry Inc (NASDAQ:BEAT), which is in the healthcare business, and is based in United States, received a lot of attention from a substantial price increase on the NasdaqGS over theRead More...
Considering the rising popularity of PBM, CRO and EHR in the U.S. Medical Services industry, these three picks might be money-spinning choices for investors.
Inc. doubled the investigative budget for a group of unsecured creditors in its bankruptcy, among the concessions the diabetes-management company made to win court approval of its financing and a process to auction off its assets. A group of unsecured creditors of publicly traded ActiveCare, however, raised a slew of objections to the sales timeline and bankruptcy financing, saying the “rushed” process discouraged bidding and hindered an investigation into past dealings.
At the urging of secured lender Partners for Growth, which is providing $800,000 in bankruptcy financing, ActiveCare agreed to sell itself to BioTelemetry, whose Telcare Inc. unit has supplied glucometers and glucose testing strips to ActiveCare. ActiveCare has also borrowed money from BioTelemetry, which is owed a total of almost $4.1 million in the bankruptcy.
NEW YORK, Aug. 06, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of BioTelemetry, ...
Right from the top brass to research analysts, constant earnings growth enthralls everyone. And why not? If the company doesn’t make money, it won’t stand the test of time. Take a company’s revenues over a given period of time, subtract the cost of production and you will have its earnings!Source: Shutterstock
The Malvern, Pennsylvania-based company said it had net income of 29 cents per share. Earnings, adjusted for non-recurring costs, came to 46 cents per share. The results surpassed Wall Street expectations. ...
Company Delivers Record Results Raises Full-Year Guidance. MALVERN, Pa., July 25, 2018-- BioTelemetry, Inc., the leading remote and wireless medical technology company focused on the delivery of health ...
MALVERN, Pa., July 17, 2018-- BioTelemetry, Inc. will release its second quarter 2018 earnings on Wednesday, July 25 at 4:00 PM Eastern Time.. The BioTelemetry quarterly conference call will be held at ...